Goldman Sachs downgraded Globus Medical (NYSE: GMED) from Buy to Neutral with a price target of $18.00 (from $19.00).

This article: 158 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE